Positive immunomagnetic CD34⁺ cell selection in haplo-identical transplants in β-thalassemia patients: removal of platelets using an automated system

References

• Voso MT, Hohaus S, Moos M, Pförsich M, Cremer FW, Schlenk RF, . Autografting with CD34 + peripheral blood stem cells: retained engraftment capability and reduced tumour cell content. Br J Haematol 1999;104: 382–91.
   PubMed Web of Science ®Google Scholar
• Bruno A, Caravita T, Adorno G, Del Poeta G, Venditti A, Stasi R, . Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors. Transfus Apher Sci 2002;26: 103–10.
   PubMed Web of Science ®Google Scholar
• Braakman E, Schuurhuis GJ, Preijers FW, Voermans C, Theunissen K, van Riet I, . Evaluation of ‘out-of-specification’ CliniMACS CD34-selection procedures of hematopoietic progenitor cell-apheresis products. Cytotherapy 2008;10: 83–9.
   PubMed Web of Science ®Google Scholar
• Dykes JH, Toporski J, Juliusson G, Békássy AN, Lenhoff S, Lindmark A, . Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults. Transfusion 2007;47: 2134–42.
   PubMed Web of Science ®Google Scholar
• Comoli P, Basso S, Zecca M, Pagliara D, Baldanti F, Bernardo ME, . Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant 2007;7: 1648–55.
   PubMed Web of Science ®Google Scholar
• Stainer CJ, Miflin G, Anderson S, Davy B, McQuaker IG, Russell NH. A comparison of two different systems for CD34+ selection of autologous or allogeneic PBSC collections. J Hematother 1998;7: 375–83.
   PubMedGoogle Scholar
• O'Donnell PV, Myers B, Edwards J, Loper K, Rhubart P, Noga SJ. CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts. Cytotherapy 2001;3: 483–8.
   PubMed Web of Science ®Google Scholar
• Watts MJ, Somervaille TC, Ings SJ, Ahmed F, Khwaja A, Yong K, . Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. Br J Haematol 2002;118: 117–23.
   PubMed Web of Science ®Google Scholar
• Zinno F, Landi F, Aureli V, Donfrancesco A, Isacchi G. Immunomagnetic selection of progenitor cells from peripheral blood after thawing with an automatic system in a pediatric patient with a neuroblastoma. Transfusion 2008;48: 550–2.
   PubMed Web of Science ®Google Scholar
• Arpaci F, Cetin T, Ozet A, Oysul K, Pekel A, Ataergin S, .The excessive numbers of total nucleated cells does not affect the performance of the CliniMACS. J Clin Apher 2004;19: 197–201.
   PubMed Web of Science ®Google Scholar
• Perseghin P, Gaipa G, Dassi M, Belotti D, Pogliani EM, Pioltelli P, . CD34+ stem cell recovery after positive selection of ‘overloaded’ immunomagnetic columns. Stem Cells Dev 2005;14: 740–3.
   PubMed Web of Science ®Google Scholar
• Del Fante C, Perotti C, Viarengo G, Bergamaschi P, Tinelli C, Bellotti L, . Immunomagnetic cell selection performed for HLA haploidentical transplants with the CliniMACS device: effect of additional platelet removal on CD34+ cell recovery. Stem Cells Dev 2005;14: 734–9.
   PubMed Web of Science ®Google Scholar
• Gaziev J, Sodani P, Lucarelli G. Hematopoietic stem cell transplantation in thalassemia. Bone Marrow Transplant 2008;42(Suppl l):S41.DOI: 10.1038/bmt.2008.112.
   Google Scholar
• Sodani P, Gaziev D, Polchi P, Erer B, Giardini C, Angelucci E, . New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood 2004;15;104:1201–3.
   Google Scholar
• Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev 2008;22: 53–63.
   PubMed Web of Science ®Google Scholar
• Witzens-Harig M, Heilmann C, Hensel M, Kornacker M, Benner A, Haas R, . Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells. Stem Cells 2007;25: 228–35.
   PubMed Web of Science ®Google Scholar
• Huang XJ. Current status of haploidentical stem cell transplantation for leukemia. J Hematol Oncol 2008;1:27.DOI: 10.1186/1756-8722-1-27.
   PubMed Web of Science ®Google Scholar
• Luo XH, Chang YJ, Xu LP, Liu DH, Liu KY, Huang XJ. The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT. Bone Marrow Transplant 2009;43: 29–36.
   PubMed Web of Science ®Google Scholar
• Koh LP, Rizzieri DA, Chao NJ. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors. Biol Blood Marrow Transplant 2007;3: 1249–67.
   Google Scholar
• Dey BR, Spitzer TR. Current status of haploidentical stem cell transplantation. Br J Haematol 2006;135: 423–37.
   PubMed Web of Science ®Google Scholar